KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 150 filers reported holding KURA ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $537,123 | -12.4% | 58,895 | +1.6% | 0.00% | – |
| Q2 2023 | $613,471 | -16.5% | 57,984 | -3.5% | 0.00% | – |
| Q1 2023 | $735,036 | -14.5% | 60,101 | -13.2% | 0.00% | – |
| Q4 2022 | $859,665 | -9.2% | 69,272 | -0.1% | 0.00% | – |
| Q3 2022 | $947,000 | -28.1% | 69,311 | -3.6% | 0.00% | – |
| Q2 2022 | $1,317,000 | +30.9% | 71,905 | +14.9% | 0.00% | – |
| Q1 2022 | $1,006,000 | -96.0% | 62,597 | -96.5% | 0.00% | -100.0% |
| Q4 2021 | $25,210,000 | -55.1% | 1,800,627 | -40.0% | 0.01% | -57.1% |
| Q3 2021 | $56,194,000 | +76.8% | 3,000,140 | +96.8% | 0.01% | +75.0% |
| Q2 2021 | $31,792,000 | -33.7% | 1,524,790 | -10.1% | 0.01% | -38.5% |
| Q1 2021 | $47,924,000 | +418.7% | 1,695,212 | +499.2% | 0.01% | +333.3% |
| Q4 2020 | $9,240,000 | -3.2% | 282,917 | -9.2% | 0.00% | 0.0% |
| Q3 2020 | $9,548,000 | +201.4% | 311,604 | +79.0% | 0.00% | +200.0% |
| Q2 2018 | $3,168,000 | +116.0% | 174,074 | +122.5% | 0.00% | 0.0% |
| Q1 2018 | $1,467,000 | – | 78,230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |